Current perspectives of Male Infertility induced by Immunomodulation due to Reproductive Tract Infections

Globally, approximately 15% of couples of reproductive ages suffer from reproductive sterility. Almost half of such cases involve male sterility which is normally an asymptomatic condition, and, in most cases, the condition is reversible with proper treatment. Uropathogens and ascending sexually transmitted infections (STIs) are recognized as one among many other causes of inflammatory diseases of male genital tract which in turn are common reason of male infertility. Thus, any suspicion of inflammatory infection of the male genital tract should be immediately diagnosed Followed by further clinical evaluation in order to rule out any pathogenic situation due to infection of male genital tract which can lead to male sterility. Proper recognition and timely treatment can help to overcome such problem.